The UK Facioscapulohumeral Muscular Dystrophy Patient Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,018
- 试验地点
- 2
- 主要终点
- Clinician questionnaire
研究概览
简要总结
Facioscapulohumeral Dystrophy (FSHD) is the third most common form of neuromuscular dystrophy worldwide with an estimated prevalence of one in 20,000. FSHD is an autosomal dominant genetic disease and is estimated to affect up to 3,000 people in the UK.
The patient registry facilitates a questionnaire based research study to better characterise and understand the disease in the UK, and helps to identify potential participants eligible for clinical trials.
详细描述
The UK FSHD Patient Registry (https://www.fshd-registry.org/uk/) recruits any individual, from anywhere within the United Kingdom, with a diagnosis of FSHD. The registry is sponsored by Muscular Dystrophy UK. Participants may be referred to the registry by health care professionals, genetic testing/laboratory centres who are aware of the registry etc. Alternatively, a participant may have discovered the registry via promotional activities or by their own online searches. After completing the consent process, participants are able to enter information on to the registry platform (note all forms are available to view on the registry website before joining the registry). This is an ongoing database and all participants are invited to update their information on an annual basis.
The database is designed to be self reporting, however where specialised clinical or genetic information is required, the neuromuscular specialist in charge of the participants care can be invited to provide some additional information. The participant is able to select a health care provider from a pre-populated list at registration stage, if they wish to (optional feature). This information is included in the patient information and consent. Relevant R&D approval has been recieved.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- All patients with a confirmed FSHD diagnosis (or pending diagnosis) who reside in the UK are eligible for inclusion.
排除标准
- •Any confirmed NMD other than FSHD
- •Living outside of the UK
结局指标
主要结局
Clinician questionnaire
时间窗: 12 months
Clinician reported genetic confirmation of FSHD.
FSHD Pain Questionnaire
时间窗: 12 months
Patient reported experience of pain.
Scapular fixation questionnaire
时间窗: 12 months
Patient reported experience of scapular fixation surgery.
McGill Pain Questionnaire
时间窗: 12 months
Patient reported current pain.
The Individualized Neuromuscular Quality of Life questionnaire (INQoL)
时间窗: 12 months
Patient reported quality of life.
Patient questionnaire
时间窗: 12 months
Patient reported FSHD clinical diagnosis, symptoms relating to muscle weakness, motor function, ventilation, retinal vascular disease, hearing loss, scapular fixation, family history and ethnicity.
The Short Form Health Survey (SF-36)
时间窗: 12 months
Patient reported quality of life.
次要结局
未报告次要终点
